for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

China Medical System Holdings

0867.HK

Latest Trade

11.06HKD

Change

-0.60(-5.15%)

Volume

6,292,245

Today's Range

10.96

 - 

11.36

52 Week Range

6.14

 - 

13.08

As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

China Medical System Holdings Says, Via Unit, Signed License Agreement With Cadila Healthcare

Jan 20 (Reuters) - China Medical System Holdings Ltd <0867.HK>::VIA UNIT SIGNED LICENSE AGREEMENT WITH CADILA HEALTHCARE FOR ITS PRODUCT DESIDUSTAT.

China Medical System Says Neurelis Announced U.S. FDA Approved Product Valtoco

Jan 13 (Reuters) - China Medical System Holdings Ltd <0867.HK>::NEURELIS ANNOUNCED THAT U.S. FDA APPROVED ITS PRODUCT VALTOCO (DIAZEPAM NASAL SPRAY).

China Medical System Signs Agreement With University Of Cambridge & AstraZeneca UK

Dec 5 (Reuters) - China Medical System Holdings Ltd <0867.HK>::SIGNED A COLLABORATION AGREEMENT WITH UNIVERSITY OF CAMBRIDGE AND ASTRAZENECA UK LIMITED.CO WILL INVEST IN UK BIOTECH AND LIFE SCIENCES SECTORS OVER NEXT FIVE YEARS THROUGH COLLABORATION.

Sun Pharmaceutical Industries Enters Licensing Agreement With China Medical System Holdings

Aug 16 (Reuters) - Sun Pharmaceutical Industries Ltd <SUN.NS>::SUN PHARMA AND CHINA MEDICAL SYSTEM HOLDINGS ENTER INTO LICENSING AGREEMENT FOR GENERIC PRODUCTS IN MAINLAND CHINA.TERM OF AGREEMENT TO BE 20 YEARS FROM FIRST COMMERCIAL SALE OF PRODUCTS IN MAINLAND CHINA, MAYBE EXTENDED BY 3 YRS.

China Medical System Holdings HY Turnover Up 11.7%

Aug 16 (Reuters) - China Medical System Holdings Ltd <0867.HK>::HY TURNOVER UP 11.7% TO RMB2,964.4 MILLION.HY PROFIT FOR PERIOD UP 22.2% TO RMB1,167.5 MILLION.DECLARED INTERIM DIVIDEND UP 22.6% COMPARED WITH SAME PERIOD LAST YEAR TO RMB0.1883 PER SHARE.

China Medical System Signs License Agreement With Unit Of Sun Pharmaceutical Industries

June 27 (Reuters) - China Medical System Holdings Ltd <0867.HK>::SIGNED A LICENSE AGREEMENT WITH A UNIT OF SUN PHARMACEUTICAL INDUSTRIES LTD.LICENSE AGREEMENT FOR PRODUCT TILDRAKIZUMAB FOR TREATMENT OF PSORIASIS AND PSORIATIC ARTHRITIS.

China Medical System Says Unit Signs License Agreement With Unit Of Sun Pharmaceutical Industries

June 27 (Reuters) - China Medical System Holdings Ltd <0867.HK>::UNIT SIGNS A LICENSE AGREEMENT OF CYCLOSPORINE A FOR TREATMENT OF DRY EYE DISEASE WITH UNIT OF SUN PHARMACEUTICAL INDUSTRIES.

China Medical System Holdings Posts FY Profit Attributable Of Rmb1.85 Bln

March 18 (Reuters) - China Medical System Holdings Ltd <0867.HK>::FY TURNOVER UP 1.6% TO RMB5,433.4 MILLION.FY PROFIT ATTRIBUTABLE RMB1.85 BILLION VERSUS RMB1.67 BILLION.PROPOSED FINAL DIVIDEND OF RMB0.1434 PER SHARE.

China Medical System Holdings Unit Signs Agreement With Midatech Pharma PLC

Jan 29 (Reuters) - China Medical System Holdings Ltd <0867.HK>::UNIT SIGNED A LICENSE, COLLABORATION AND DISTRIBUTION AGREEMENT WITH MIDATECH PHARMA PLC.CHINA MEDICAL SYSTEM HOLDINGS - UNIT SIGNED A LICENSE, COLLABORATION AND DISTRIBUTION AGREEMENT WITH MIDATECH PHARMA PLC.THROUGH UNIT, SIGNED SUBSCRIPTION DEAL WITH MIDATECH PHARMA TO MAKE AN EQUITY INVESTMENT IN MIDATECH PHARMA.CHINA MEDICAL SYSTEM - THROUGH AGREEMENT, GROUP WILL GAIN EXCLUSIVE RIGHTS TO DEVELOP AND COMMERCIALIZE MIDATECH PHARMA'S PRODUCTS.

China Medical System Through Unit Signs License And Collaboration Agreement With VAXIMM AG

Sept 19 (Reuters) - China Medical System Holdings Ltd <0867.HK>::GROUP THROUGH UNIT SIGNED LICENSE AND COLLABORATION AGREEMENT WITH VAXIMM AG.UNDER DEAL, GROUP GAINS EXCLUSIVE RIGHTS TO DEVELOP, COMMERCIALIZE CURRENT PHARMACEUTICAL PRODUCTS PORTFOLIO OF VAXIMM AG.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up